Clinical Trial Update: Allogeneic Stem Cell Transplantation for Patients With Multiple Myeloma [EARLY_Phase 1]

View source ↗

Summary

The clinical trial NCT02447055 evaluating allogeneic stem cell transplantation for multiple myeloma has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Snippet

Sponsor: Washington University School of Medicine | Conditions: Multiple Myeloma, Myeloma-Multiple | EARLY_Phase 1 | Status: WITHDRAWN